Table 4

Adverse events during chemotherapy (18 patients, 146 cycles)
Patients with biliary stent (n = 9) Patients without biliary stent (n = 9) All patients (n = 18)
Adverse event Grade 1/2 Grade 3/4 Grade 1/2 Grade 3/4 Grade 1/2 Grade 3/4
n (%) n (%) n (%) n (%) n (%) n (%)
Hematological
Neutropenia 3 (33 %) 3 (33 %) 3 (33 %) 1 (11 %) 6 (33 %) 4 (22 %)
Neutropenic fever 0 2 (22 %) 0 1 (11 %) 0 3 (17 %)
Anemia 6 (67 %) 2 (22 %) 7 (78 %) 0 13 (72 %) 2 (11 %)
Thrombocytopenia 3 (33 %) 3 (33 %) 5 (56 %) 0 8 (44 %) 3 (17 %)
Non-hematological
Fatigue 6 (67 %) 1 (11 %) 8 (89 %) 1 (11 %) 14 (78 %) 2 (11 %)
Anorexia 3 (33 %) 0 1 (11 %) 0 4 (22 %) 0
Mucositis 1 (11 %) 0 1 (11 %) 0 2 (11 %) 0
Nausea 5 (56 %) 0 4 (11 %) 0 9 (50 %) 0
Vomiting 0 0 2 (22 %) 0 2 (11 %) 0
Diarrhea 3 (33 %) 1 (11 %) 3 (33 %) 1 (11 %) 6 (33 %) 2 (11 %)
Peripheral neuropathy 1 (11 %) 0 5 (56 %) 0 6 (33 %) 0
Alopecia 6 (67 %) 0 6 (67 %) 0 12 (67 %) 0

Hosein et al.

Hosein et al. BMC Cancer 2012 12:199   doi:10.1186/1471-2407-12-199

Open Data